Sézary Syndrome
📧 Sign up to get email alerts when something new happens for Sézary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome [Phase 1]
Phase 1 clinical trial evaluating the combination of duvelisib and nivolumab for stage IIb–IVB mycosis fungoides and Sézary syndrome; trial …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)
A clinical trial update investigating lymphocyte phenotype in autosomal recessive congenital ichthyoses due to NIPAL4 mutation (NIPAL4-nEDD)…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas [Phase 2]
Phase 2 clinical trial update evaluating pembrolizumab with mogamulizumab in advanced-stage, relapsed/refractory cutaneous T-cell lymphoma, …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Extracorporeal Photopheresis in Sezary Syndrome
This clinical trial update shows that recruitment is ongoing for a study evaluating extracorporeal photopheresis in Sézary syndrome. No effi…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This clinical trial update indicates ongoing recruitment for a University of Pittsburgh study collecting blood, urine, and tissue samples fr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
A clinical trial update notes ongoing recruitment for systemic therapies in the treatment of cutaneous T-cell lymphoma, including mycosis fu…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Tissue Repository: CTCL Collection Protocol
This clinical trial update describes a tissue repository protocol for collecting samples related to cutaneous T-cell lymphoma (CTCL) and rel…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This Stanford University clinical trial aims to identify prognostic factors in Mycosis fungoides and Sézary syndrome and is currently recrui…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of extracorporeal photopheresis and mogamulizumab for erythrodermic cutaneous T-cell lymphoma, curr…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of ST-001 nanoFenretinide for relapsed/refractory T-cell non-Hodgkin lymphoma is currently recruiting, targeting multiple T-ce…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
A clinical trial update on mogamulizumab (Poteligeo) assessing safety and efficacy through use-result surveillance in patients with mycosis …
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy [Phase 4]
Phase 4 update evaluating KW-0761 (mogamulizumab) for Mycosis fungoides or Sézary syndrome in Chinese patients who have previously received …
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
A US-based prospective study examining mogamulizumab-associated rash in patients with mycosis fungoides or Sézary syndrome who are treated w…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome [Phase 2]
Clinical trial evaluating mogamulizumab with low-dose total skin electron beam therapy in Sézary syndrome and mycosis fungoides, Phase 2, cu…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
This clinical trial is recruiting to evaluate predictive and prognostic biomarkers in patients with Mycosis fungoides and Sézary syndrome.
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Prospective multicenter study evaluating flow cytometry detection of the KIR3DL2 marker for diagnosing Sézary syndrome, assessing therapeuti…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)
Real-world observational study PROSPER evaluating mogamulizumab (Poteligeo) in adults with mycosis fungoides and Sézary syndrome; the study …
-
CLINICAL_TRIALS research · 2014-05-28Clinical Trial Update: In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
An in vitro study from the University of Pittsburgh evaluates immune responses in cutaneous T-cell lymphoma, including Sézary syndrome and m…